Intracranial Therapeutic Delivery Market revenue will climb to US$ 4.2 Bn by the end of 2032 – Persistence Market Research New York, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The global intracranial therapeutic delivery market is currently valued at around US$ 1.6 Bn and is anticipated to progress at an impressive CAGR of 7.9%...

Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today announced the successful closing of its Series Seed Preferred Stock...